Zenicor (ZENI) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
31 Jul, 2026Executive summary
Revenue for Q2 2026 was 7,365 KSEK, up 5% year-over-year; net profit reached 105 KSEK compared to a loss of -87 KSEK in Q2 2025.
H1 2026 revenue totaled 15,134 KSEK, a 7% increase year-over-year; net profit for H1 was 270 KSEK versus a loss of -533 KSEK in H1 2025.
Growth driven by new and existing customers, new contracts, and high usage rates; positive feedback from clients.
Extended procurement agreement with Region Dalarna by two years, now valid through 2028.
Launch of Zenicor Solution, including Zenicor Flex, in the UK with first pilot customers secured.
Financial highlights
Q2 2026 net sales: 7,365 KSEK (Q2 2025: 7,043 KSEK); H1 2026 net sales: 15,134 KSEK (H1 2025: 14,128 KSEK).
Q2 2026 net profit: 105 KSEK (Q2 2025: -87 KSEK); H1 2026 net profit: 270 KSEK (H1 2025: -533 KSEK).
Earnings per share Q2 2026: 0.004 SEK (Q2 2025: -0.006 SEK); H1 2026: 0.010 SEK (H1 2025: -0.038 SEK).
Operating result Q2 2026: 511.7 KSEK (Q2 2025: 126.5 KSEK).
Cash flow from operations for H1 2026: 2,473 KSEK.
Outlook and guidance
Anticipates increased growth rate in H2 2026 due to new contracts and higher usage from both new and existing customers.
Expects balanced cash flow in coming quarters, supported by cost control and stable debt levels.
Sees significant growth potential in the private provider segment and UK market.
Latest events from Zenicor
- Q1 2026 saw 10% revenue growth, positive earnings, and major new contracts in core markets.ZENI
Q1 2026 - Strong revenue growth and profitability in 2025, with robust outlook for 2026.ZENI
Q4 2025 - Secured rights issue and new contracts drive growth in AI-powered arrhythmia diagnostics.ZENI
Investor Update - Q3 2025 revenue up 10% year-over-year, with positive profit and new growth financing secured.ZENI
Q3 2025 - Q2 2025 saw 10% revenue growth, positive profit, and key wins in Finland and the UK.ZENI
Q2 2025 - Revenue growth and positive operating income mark a strong Q3, despite liquidity challenges.ZENI
Q3 2024 - Q2 2024 saw record Q2 revenue, positive operating profit, and strengthened liquidity.ZENI
Q2 2024 - Record Q1 revenue and UK contracts drive Zenicor's return to profitability.ZENI
Q1 2025 - Record revenue and a return to profit set the stage for accelerated growth in 2025.ZENI
Q4 2024